On May 16th, The Council on Strategic Risks (CSR) hosted an event on the federal government’s strategy for driving innovation in biomanufacturing. The panel event featured expert perspectives from Dr. Georgia Lagoudas, Mr. Maynard Holliday, and Dr. Anup Singh. The panelists discussed how the federal interagency is positioning itself to capitalize on the transformative effects…
On May 12th, CSR hosted an event with former leaders from HHS’s Administration for Strategic Preparedness and Response (ASPR) on reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA).
We commend the G7 nations for seizing the moment by recommitting to long-held norms, encouraging dialogue, and setting priorities for future actions. This is just one step, but it is the right one.
On May 16 at 12:00pm ET, CSR will host a public event focused on this critical area of progress in U.S. biomanufacturing resilience.
Biological threats to national security pose a unique combination of risk and opportunity, with the potential for large-scale damage and the bargain of mitigating them.
CSR is committed to developing achievable nuclear weapons risk reduction measures, and to mentoring—and learning from—potential future leaders in this field of work.
CSR’s Dan Regan talks to IBBIS Executive Director Piers Millett on the Biological Weapons Convention, the future of its implementation, and how verification could be pursued amid shifting technologies.
Habitat fragmentation, ecosystem degradation, land conversion, deforestation, and wildlife trade have all contributed to the steady increase in disease spillover over the past several decades.
How the United States and its NATO allies react in the coming days will play a major role in shaping the trajectory of the following decades.
Taking steps now to enhance surveillance, accelerate vaccine testing and development, and improve the security of farms, will help prevent H5N1 from becoming the next pandemic. It is not too late to tackle this threat, but it is ultimately up to us to take action.